A former Georgia mayor filed a morcellator cancer lawsuit in early April 2015 in the U.S. District Court for the Northern District of Georgia alleging that the use of a power morcellator caused cancer cells to be spread throughout her abdomen and pelvis. The laproscopic medical device, which is used in certain types of surgeries, has been linked to the spread of cancerous cells in a number of patients, and morcellator cancer lawsuits have been filed in Georgia and other states.
If you or a loved one developed cancer after a procedure involving a morcellator, contact Attorney Group for Georgia for more information. We can answer your questions in a free, no-obligation consultation, and if you have a case, we can connect you with an affiliated attorney who can file a Georgia morcellator cancer lawsuit on your behalf and help you seek the compensation to which you may be entitled. The time to pursue a claim is limited, so contact us today.
Use of Power Morcellators May Spread Cancerous Tissue
The plaintiff claims that she underwent a laparoscopic hysterectomy in January 2011. During the procedure, which is generally considered minimally invasive, surgeons are alleged to have used Ethicon’s Gynecare tissue morcellator to remove uterine tissue from her body. The plaintiff claims that Vention Medical Inc., Ethicon, and Johnson & Johnson failed to disclose risks of the morcellator spreading cancerous tissue and upstaging an already aggressive cancer.
A tissue biopsy taken during the surgery reportedly showed endometrial stromal sarcoma/leiomyosarcoma. The patient was declared cancer-free until April 2013, when she claims that she was diagnosed with a recurrence of the condition in which her left anterior abdominal wall and pelvis were affected. According to the plaintiff, this recurrence of cancer was caused by the power morcellator used in her laproscopic hysterectomy.
The allegations raised in the Georgia morcellator cancer lawsuit are similar to other claims pursued by women who have been diagnosed with cancers such as leiomyosarcoma and endometrial stromal sarcoma following a uterine fibroid removal or laparoscopic hysterectomy. In November 2014, the U.S. Food and Drug Administration warned against using laparoscopic power morcellators to remove uterine fibroids in a news release.
Contact Us For More Information. The Time to Pursue a Claim is Limited.
If you or a loved one developed cancer following a procedure involving a morcellator, contact Attorney Group for Georgia to learn more about your options. We can answer your questions, and if you have a case, we can connect you with an affiliated morcellator cancer attorney. Your call is free and without obligation. However, state laws limit your time to pursue a claim, so contact us today.
